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OBJECTIVES We sought to determine whether there are age-related differences in vasovagal syncope.
BACKGROUND In those with suspected vasovagal (neurocardiogenic) syncope, tilt testing demonstrates
different hemodynamic responses. These responses may be age related, reflecting differing
underlying pathophysiology.
METHODS Using a two-stage tilt protocol with glyceryl trinitrate (GTN) provocation, 505 consecutive
syncopal patients were studied. Their baseline characteristics and hemodynamic responses
during both early and tilt-induced collapse were analyzed. Hemodynamic responses were
classified using the VAsovagal Syncope International Study (VASIS) criteria: mixed,
cardioinhibition, severe cardioinhibition/asystole, pure vasodepression, chronotropic incom-
petence, and excessive heart rate rise. Multivariate regression analyses were performed to
determine the associations of the baseline clinical characteristics (including age) and the
tilt-induced hemodynamic responses.
RESULTS Thirty-three patients were unable to tolerate tilt testing. Age was independently associated
with distinct responses during tilt. Chronotropic incompetence was predicted by increasing
age (odds ratio [OR] 1.04, p  0.0002). Younger age predicted an excessive heart rate rise
(OR 0.97, p  0.0005). Pure vasodepression was more common in the older group (65
years; OR 29.5, p  0.0001), whereas severe cardioinhibition was much less common in the
older age group (OR 0.18, p  0.0001).
CONCLUSIONS There appear to be distinct pathophysiologies underlying vasovagal syncope in different age
groups. Young people appear to have excessive cardiac and autonomic responses to stress,
whereas older patients appear to have a more generalized cardiovascular decline, with
attenuated cardiac and autonomic responses to stress. (J Am Coll Cardiol 2003;41:1004–7)
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In those with syncope of unknown origin but a suspected
vasovagal (neurocardiogenic) pathophysiology, tilt testing
with drug provocation has become an integral part of the
assessment (1–3). Recently, attention has focused on the
heart rate (HR) and blood pressure (BP) (hemodynamic)
responses that patients display while attempting to maintain
an upright posture during the tilt test and, ultimately,
during collapse (3–5). These hemodynamic patterns have
been classified by the VAsovagal Syncope International
Study (VASIS) into distinct subgroups based on these HR
and BP responses (4). The diverse nature of the responses
seen suggests that there may be differences in the underlying
pathophysiology (5). How these different hemodynamic
responses relate to age remains less well studied. In this
study, we assessed whether there are distinct associations
between different tilt-induced hemodynamic patterns and
age. This has implications not only for the understanding of
vasovagal syncope but also for more effective targeting of
therapy.
METHODS
Study population. Patients with one or more syncopal
attacks were diagnosed as having unexplained syncope if no
cause was found after a standard diagnostic evaluation. This
consisted of a careful history and physical examination, full
clinical neurologic assessment, routine laboratory tests, su-
pine and orthostatic BP measurements, and a 12-lead
electrocardiogram consistent with the European Society of
Cardiology Task Force on Syncope (6). Patients who had
no evidence of structural heart disease or whose disease was
sufficiently mild not to require specific therapy (e.g., aortic
stenosis treated by valve replacement) were included. Using
this diagnostic approach, other interventions, such as elec-
trophysiologic study, were not performed before the tilt test.
Head-up tilt testing. The tilt test was performed by means
of an electrically controlled tilt table with a footboard for
weight bearing. Blood pressure, HR, and rhythm were
continuously monitored and recorded. Heart rate data were
obtained as a series of R-R intervals with resolution of 1 ms.
Blood pressure was measured by means of either a Finapress
2300 (Ohmeda, Louisville, Colorado) or Portapres (TNO-
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BMI Amsterdam, The Netherlands) photoplethysmo-
graphic device, which provide continuous non-invasive
beat-to-beat determination of finger arterial pressure by the
Pena`z (7) volume-clamp method, which accurately reflects
changes (8). No invasive instrumentation was used during
stress.
The two-stage tilt protocol with glyceryl trinitrate
(GTN) provocation. The head-up tilt test was performed
after an initial observation with the patient in the supine
position for 10 min. The test consisted of two consecutive
stages. In stage 1, patients were tilted at 60° for up to 45 min
without medication, in accordance with the Westminster
drug-free protocol (1). If syncope (or limiting symptoms)
did not develop, patients entered stage 2. They received 300
to 400 g sublingual GTN and continued to be tilted for
another 20 min. If syncope (or limiting symptoms) occurred
during the test, the tilt table was rapidly adjusted to return
the patient to the supine position, and the study was
terminated.
Data collection and processing. Data were obtained for a
supine rest period of 10 min throughout the period of tilt,
and for 2 min after return to the supine position. Data from
each patient were reviewed and edited manually to remove
artifacts. Then, HR and BP were averaged for the rest
period, for each minute of the tilt, and for the post-tilt
period.
Data statistical analysis. BASELINE VARIABLES. Age was
analyzed both as a continuous variable and as a discrete
variable, with the population being divided into three
groups: those 35 years old; 36 to 64 years; and 65 years.
The other independent variables adjusted for were female
gender, history of heart disease, postural hypotension, and
use of GTN provocation.
CLASSIFICATION OF THE COLLAPSE PATTERN. There were
six potential outcomes of tilt testing: a positive result (with
four sub-classes), a negative result, or incomplete. A test was
considered incomplete if the patient could not complete the
tilt-test protocol. In those who completed the tilt test, a
result was considered positive if the patient had syncope or
limiting symptoms (i.e., collapse) during tilt testing. All the
positive tests were classified according to the VASIS clas-
sification (4). The VASIS study classifies the collapse
according to the pattern of BP and HR changes, the
changes in early tilting, and carotid sinus syndrome, sum-
marized as follows: type 1—mixed BP and HR fall without
severe bradycardia; type 2A—cardioinhibition (BP falls
before HR); type 2B—severe cardioinhibition (HR falls
before or coincident with BP and/or asystole); type 3—BP
falls without HR falling. In addition, there are atypical HR
responses: chronotropic incompetence (minimal or no rise
in HR [i.e., 10% increase from the supine pre-tilt level])
or an excessive HR rise before syncope (i.e., 130 beats/
min). These criteria have recently been modified (5), but the
modifications were not used in the present study.
LOGISTIC REGRESSION MODELING. The logistic regression
modeling analysis was undertaken in two parts: 1) Predic-
tors of atypical HR responses in early tilt testing. In part 1,
the outcomes of interest were the two atypical HR responses
in early tilt. The baseline clinical variables (e.g., age, gender,
and so forth) were assessed as potential independent vari-
ables/predictors of these atypical HR responses. 2) Predic-
tors of the final outcomes of tilt testing. In part 2, the
outcomes of interest were six final outcomes. The baseline
variables and the two atypical HR responses were assessed as
potential independent variables/predictors of these final
outcomes.
During logistic regression modeling, the criteria for
acceptance were, first, the odds ratio (OR) with its 95%
confidence interval (CI) and p value of each of the inde-
pendent variables and, second, the p value of the Hosmer-
Lemeshow goodness-of-fit chi-squared test of the model.
RESULTS
A total of 505 consecutive patients were studied. Of these,
33 (6.3%) were unable to tolerate tilt testing, usually for
reasons of musculoskeletal discomfort, and their results were
classified as incomplete; hence, 472 patients completed the
protocol. Patients were grouped according to age. Table 1
shows the distribution of the baseline clinical characteristics,
two atypical HR responses, and six final outcomes during
tilt testing by age group.
Predictors of atypical HR responses in early tilt testing.
Using logistic regression, chronotropic incompetence was
predicted by increasing age (OR 1.04, 95% CI 1.02 to
1.07; p  0.0002), whereas decreasing age predicted an
excessive HR rise (OR 0.97, 95% CI 0.95 to 0.98; p 
0.0005).
Predictors of final outcomes of tilt testing. Older age was
associated with an incomplete tilt test and pure vasodepres-
sion. Younger age was associated with severe cardioinhibi-
tion. The associations between the six final outcomes and
age group are shown in Table 2. The quoted p value is that
for the stepwise inclusion (or exclusion) of the age variable
as a whole in (or from) the given logistic regression model.
The modeling process does not provide separate p values for
each individual level within the age variable, but it does
provide individual ORs and 95% CIs for each level with
respect to the lowest level (within the age variable).
Abbreviations and Acronyms
BP  blood pressure
CI  confidence interval
GTN  glyceryl trinitrate
HR  heart rate
OR  odds ratio
VASIS  VAsovagal Syncope International Study
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DISCUSSION
Analysis of the hemodynamic responses during early tilt
testing and at the time of collapse show age-related differ-
ences. There appears to be a gradient in the age-related
hemodynamic responses from the young to the old age
group (Table 1), with the middle group’s responses being
closer to those of the older rather than younger group. The
middle and old groups were more likely to not be able to
complete the tilt test. This was the effect of the greater
likelihood of musculoskeletal and other non-cardiac co-
morbidities. There was a relatively consistent finding of a
mixed (VASIS-1) response being present in 40% of
patients in all ages. The mixed (VASIS-1) response may
represent a genuine sub-type of vasovagal response or
responses with a distinct pathophysiology or pathophysiol-
ogies. However, it is possible that the mixed response
represents a false-positive finding. In their study of normal
subjects undergoing tilt testing, Petersen et al. (9) found
that of the 16 (13% of total) with positive results, 14 had
mixed (VASIS-1) responses.
In older patients, chronotropic incompetence was more
frequent. This phenomenon has been previously demon-
strated in those undergoing exercise stress testing (10) and
in candidates for pacing with sino-atrial disease (11,12).
The aging heart and/or autonomic nervous system are
unable to make the appropriate compensatory HR changes
for the stress induced by tilt testing. This may mirror the
real world, where changes in cardiac loading are not
compensated for by appropriate changes in HR, which is
fixed. It is uncertain whether the heart or autonomic
nervous system is the primary problem. The data suggest
that it may be both. The increasing frequency of chrono-
tropic incompetence with increasing age was independent of
that of heart disease.
There also appear to be distinct findings in the younger
patients. Younger patients were more likely to have extreme
changes in HR. This may be an “excessive HR rise” seen in
early tilt testing or severe cardioinhibition/asystole seen at
the time of collapse. Thus, unlike older patients, younger
patients may have inappropriately overactive cardiac and
autonomic responses.
Clinical importance. There appear to be distinct patho-
physiologies underlying vasovagal syncope in different age
groups. The pathophysiology in young people appears to be
characterized by excessive cardiac and autonomic responses
to stress, whereas in older patients, the pathophysiology
appears to be a more generalized cardiovascular decline,
with attenuated cardiac and autonomic responses to stress.
Therapeutic pacing can compensate for and correct bra-
dycardia. Preliminary data suggest that pacing may have a
Table 1. Distribution of Baseline Characteristics, Atypical Heart Rate Responses in Early Tilt
Testing, and Final Outcomes Between the Age Groups
Characteristic or Tilt Response/Outcome
<35 years
(n  165)
36–64 years
(n  169)
>65 years
(n  171) p Value*
Female (n  259) 56.4 42.0 55.6 0.013
Heart disease (n  69) 0 8.9 31.6  0.0005
Postural hypotension (n  43) 1.8 3.6 19.9  0.0005
GTN provocation necessary (n  280) 47.3 59.8 59.1 0.036
Chronotropic incompetence (n  31) 0.0 5.9 12.3  0.0005
Excessive heart rate rise (n  63) 24.9 7.1 5.9  0.0005
Unable to tolerate tilt testing (n  33) 1.8 8.9 8.8 0.012
Negative result (n  104) 15.1 26.0 20.5 0.049
Mixed response (VASIS-1) (n  194) 43.6 37.9 33.9 0.185
Cardioinhibitory response (VASIS-2A) (n  54) 5.5 9.5 9.9 0.265
Severe cardioinhibitory response/asystole
(VASIS-2B) (n  89)
33.3 14.8 5.3  0.0005
Pure vasodepression (VASIS-3) (n  43) 0.6 3.0 21.6  0.0005
*Conchran-Mantel Haenszel. Data are presented as the percentage of patients.
GTN  glyceryl trinitrate; VASIS  VAsovagal Syncope International Study, types 1, 2A, 2B, and 3.
Table 2. Comparison of Final Outcomes in the 36–64 and 65 Years-Old Groups With
Respect to the 35 Years-Old Group
Tilt-Test Response
36–64 Years
(n  169) OR (CI)*
>65 Years
(n  171) OR (CI)* p Value
Incomplete tilt test 8.8 (2.36–32.8) 7.63 (2.10–27.8) 0.0024
Negative tilt test NS NS NS
Mixed response (VASIS-1) NS NS NS
Cardioinhibitory response (VASIS-2A) NS NS NS
Severe cardioinhibitory response/asystole
(VASIS-2B)
0.34 (0.19–0.60) 0.18 (0.076–0.41)  0.0001
Pure vasodepression (VASIS-3) 4.4 (0.508–38.8) 29.5 (3.9–22.4)  0.0001
*Odds ratio (OR) with 95% confidence interval (CI) compared with the 35 years-old group (n  165).
NS  no significant association; other abbreviation as in Table 1.
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beneficial role in preventing and/or delaying syncope in
those with significant bradycardia (cardioinhibition) re-
vealed by tilt testing (13–16). Negatively chronotropic
agents, especially beta-blockers, may be beneficial for con-
trolling excessive tachycardia. Fluid-retaining drugs, such as
fludrocortisone, and vasoconstrictive drugs, such as mido-
drine, may be useful in those in whom hypotension is the
primary problem. These patients may also benefit from
support stockings.
Non-invasive or non-pharmacologic approaches may also
have a role. Tilt training appears to help in selected patients
(17). It may be possible to use voluntary cortical mecha-
nisms to dampen and/or compensate for cardiac/autonomic
reflex effects.
These results need now to be seen in the light of the
recently published International Study on Syncope of Un-
certain Etiology (ISSUE) (18). In relatively small numbers
of patients, the use of an implantable loop recorder has
shown that asystole is more frequently associated with
spontaneous syncope than with tilt-induced syncope. The
data from ISSUE need amplification. However, the data
presented here remain valid in a physiological sense and
pertinent for the selection of therapy. When more data from
implantable loop recorders are available, it is likely that the
observations presented will apply.
Study limitations. It may be considered important to
ensure that the findings of the test are reproducible. We did
not repeat the test in our patients. It is unclear whether
individual tilt-test responses are reproducible (19). Repeat
tilt testing for diagnostic purposes may have a limited role.
Once patients have been tilted, their responses may change
because they are aware of what to expect and attempt to
respond. There is also an absence of a control group (i.e.,
age-matched subjects without syncope of unknown origin).
There are other changes in the vasovagal response, such
as respiratory patterns (20). These may also vary according
to age. However, at present, the two changes that can be
most accurately and readily measured are HR and BP;
hence, the study has been confined to these.
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